Skip to content
Disclosery

Parrish Capital LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Parrish Capital LLC on GSK, newest first. How the timeline and the estimate are built.

Parrish Capital LLC held 30,927 GSK shares at 2026-09-30 per its 13F-HR filed 2026-10-01.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 30,927 shares
    Change vs previous 13F +1,317 shares

    1.45% of the 13F portfolio, value $1,489,754.

    13F-HR 0002131053-26-000006 filed by Parrish Capital LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 29,610 shares
    Change vs previous 13F +22 shares

    1.5% of the 13F portfolio, value $1,552,156.

    13F-HR 0002131053-26-000004 filed by Parrish Capital LLC
    Accepted , ingested

  3. period ended2026-03-31
    13F 29,588 shares
    Change vs previous 13F -639 shares

    1.46% of the 13F portfolio, value $1,632,962.

    13F-HR 0002131053-26-000003 filed by Parrish Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 30,227 shares
    Change vs previous 13F not available

    1.34% of the 13F portfolio, value $1,482,332.

    13F-HR 0002131053-26-000002 filed by Parrish Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).